VPIM
IRWD icon

Vanguard Personalized Indexing Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$250K Sell
71,118
-3,721
-5% -$15.3K ﹤0.01% 1708
2025
Q4 		$252K Buy
74,839
+2,133
+3% +$5.54K ﹤0.01% 1607
2025
Q3 		$95.2K Buy
72,706
+22,029
+43% +$22.8K ﹤0.01% 1827
2025
Q2 		$36.3K Buy
+50,677
New +$39.8K ﹤0.01% 1859
2023
Q3 		– Sell
-12,856
Closed -$137K – 1517
2023
Q2 		$137K Buy
+12,856
New +$138K ﹤0.01% 1382

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Vanguard Personalized Indexing Management's IRWD Position: Q1 2026 in Review

Vanguard Personalized Indexing Management reduced its Ironwood Pharmaceuticals (IRWD) stake by 5% in Q1 2026, selling an estimated $15.3K and leaving 71,118 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #1708.

Vanguard Personalized Indexing Management first reported a position in IRWD in Q2 2023 and has held it in 5 quarters since. The position peaked at $252K in Q4 2025. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Vanguard Personalized Indexing Management held 71,118 shares of Ironwood Pharmaceuticals worth $250K as of Q1 2026.
  • Vanguard Personalized Indexing Management sold 3,721 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $15.3K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #1708 holding.
  • Vanguard Personalized Indexing Management first reported a position in Ironwood Pharmaceuticals in Q2 2023 and has held it in 5 quarters since.
  • Vanguard Personalized Indexing Management's Ironwood Pharmaceuticals position peaked at $252K in Q4 2025.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.